Affordable Access

Publisher Website

Susceptibility ofin VitroStimulated PBMC to Infection with NSI HIV-1 Is Associated with Levels of CCR5 Expression and β-Chemokine Production

Authors
Journal
Virology
0042-6822
Publisher
Elsevier
Publication Date
Volume
267
Issue
2
Identifiers
DOI: 10.1006/viro.1999.0111
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Susceptibility of PHA/rIL-2-stimulated PBMC from 14 healthy blood donors for NSI HIV-1 infection was analyzed in relation to CCR5 expression and β-chemokine production. After 1 week of culture in the presence of rIL-2, but not at the moment of inoculation, CCR5 surface expression was positively and β-chemokine production was inversely associated with susceptibility to NSI HIV-1 infection. Surprisingly, no association was observed between CCR5 genotype and in vitro NSI HIV-1 susceptibility, which was in agreement with similar levels of CCR5 surface expression and β-chemokine production in CCR5Δ32/+ and CCR5 +/+ PBMC after PHA/rIL-2 stimulation. In contrast to what was observed in vitro, CCR5 genotype did associate with CCR5 surface expression levels in vivo in resting as well as in activated CD4 + T cell populations that were identified by the expression of CD45RO, CD27, HLA-DR, and CD69. The association between CCR5 expression and susceptibility to infection by NSI HIV-1 observed in vitro might offer an explanation for the in vivo observed protective effect of CCR5 polymorphisms that influence CCR5 expression on disease progression.

There are no comments yet on this publication. Be the first to share your thoughts.